Shigeru Koga

Title: Shigeru Koga: Innovator in Pharmaceutical Chemistry

Introduction

Shigeru Koga is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on diphenyl sulfide derivatives. His research focuses on developing compounds with specific biological activities that can lead to new therapeutic options.

Latest Patents

Koga holds a patent for a diphenyl sulfide derivative and a pharmaceutical product that contains it as an active ingredient. The patent addresses the need for a compound that exhibits excellent S1P3 antagonist activity. The invention is represented by a general formula where R1 is an alkoxy group with 1-6 carbon atoms, R2 is either a propyl or allyl group, X can be methylene or an oxygen atom, and Z is a halogen atom. This discovery is a result of extensive research aimed at producing a compound with S1P3 antagonist activity.

Career Highlights

Shigeru Koga is associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical products. His work has the potential to impact the development of new medications that target specific receptors in the body.

Collaborations

Koga collaborates with esteemed colleagues such as Kumi Ishikawa and Yasushi Kohno. Their combined expertise enhances the research efforts at Kyorin Pharmaceutical Co., Ltd.

Conclusion

Shigeru Koga's innovative work in the field of pharmaceutical chemistry exemplifies the importance of research in developing new therapeutic agents. His contributions, particularly in the area of S1P3 antagonists, highlight the potential for advancements in medical treatments.